The Food and Drug Administration is weighing the benefits and risks of two experimental colon cancer screening tests that use DNA from a patient's stool to detect dangerous tumors and growths.
http://ift.tt/OUc0ld
http://ift.tt/OUc0ld
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment